• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>PNC Capital Trust E Pref Share

PNC Capital Trust E Pref Share

  1. European Commission Grants Orphan Drug Designation to ALXN1007 for the Treatment of Patients with Graft-Versus-Host Disease (GVHD)

    European Commission Grants Orphan Drug Designation to ALXN1007 for the Treatment of Patients with Graft-Versus-Host Disease (GVHD)

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.